July 30, 2021 - ROSEN LOGO.jpg
ANVS BREAKING ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Annovis Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ANVS
19 août 2021 18h15 HE | The Rosen Law Firm PA
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
CenExel Clinical Research Acquires Advanced Memory Research Institute
19 août 2021 08h12 HE | CenExel Clinical Research
Salt Lake City, Utah, Aug. 19, 2021 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of Advanced Memory Research Institute (“CenExel AMRI”), the largest...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer’s Association International Conference 2021 (AAIC)
19 juil. 2021 07h00 HE | Athira Pharma, Inc.
BOTHELL, Wash., July 19, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease
06 juil. 2021 07h00 HE | Athira Pharma, Inc.
BOTHELL, Wash., July 06, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
retro.jpg
Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with Progressive Supranuclear Palsy (PSP)
30 juin 2021 07h00 HE | Retrotope
LOS ALTOS, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- Retrotope, a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class therapies for degenerative diseases,...
22157.jpg
Outlook on the Neurological Diseases Treatment Global Market to 2029 - Key Drivers, Challenges and Opportunities
29 avr. 2021 07h18 HE | Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Neurological Diseases Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
21 avr. 2021 07h00 HE | Athira Pharma, Inc.
BOTHELL, Wash., April 21, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
Athira Pharma Logo RGB@1200px.jpg
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
08 avr. 2021 07h00 HE | Athira Pharma, Inc.
Featuring leading neurologist Marwan Sabbagh, M.DWebinar to be held Thursday, April 15, at 1:30 p.m. PT / 4:30 p.m. ET BOTHELL, Wash., April 08, 2021 (GLOBE NEWSWIRE) -- Athira Pharma, Inc....
logo-brainhq-hi-res-hori.png
$44 Million NIH Grant to See if Dementia Can Be Prevented
06 avr. 2021 08h00 HE | Posit Science
SAN FRANCISCO, April 06, 2021 (GLOBE NEWSWIRE) -- Researchers at the University South Florida in Tampa have received a $44.4 million grant from the National Institutes of Health (NIH) for the...
Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit 
11 mars 2021 07h05 HE | Annovis Bio, Inc.
BERWYN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Annovis Bio, Inc., ANVS, today announced that Maria Maccecchini, PhD, Founder, President and CEO, will be attending the Q1 Virtual...